Arama Sonuçları - Mathias Hanel

Case Report: Leptomeningeal involvement in chronic lymphocytic leukemia patients with central nervous system infection: extramedullary manifestation or transmigration of leukocytes... Yazar: Tianjiao Zhang, Annette Schuller, Yi Li, Regina Herbst, Korinna Jöhrens, Nicole Schleicher, Ronny Maurer, Mathias Hänel

Tam Metin Erişim

S114: OUTCOME OF OLDER PATIENTS (>55 YRS) WITH NEWLY DIAGNOSED PH/BCR:ABL POSITIVE ALL PROSPECTIVELY TREATED ACCORDING TO PEDIATRIC-BASED, AGE-ADAPTED GMALL PROTOCOLS Yazar: Fabian Lang, Heike Pfeifer, Simon Raffel, Walter Fiedler, Maher Hanoun, Mathias Hänel, Bernd Spriewald, Andreas Viardot, Vladan Vucinic, Hubert Serve, Dieter Hoelzer, Nicola Gökbuget

Tam Metin Erişim

P947: TREATMENT PATTERNS AND OUTCOMES OF RE-INDUCTION THERAPIES PRIOR TO STEM CELL TRANSPLANTATION IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED IN CLINICAL PRACTIC... Yazar: Sandra Sauer, Monika Engelhardt, Karolin Trautmann-Grill, Christoph Kimmich, Mathias Hänel, Martin Schmidt-Hieber, Hans Salwender, Carmen Flossmann, Hiltrud Heckmann, Franziska Ertel, Andrea Friederich, Sachin Patel, Sabine Piesch, Barbara Thun, Marc S. Raab

Tam Metin Erişim

Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance Yazar: Christian Schmidt, Gabriel Scheubeck, Vindi Jurinovic, Martin Sökler, Roswitha Forstpointner, Christian Buske, Andreas Viardot, Ulrich Keller, Ullrich Graeven, Reinhard Marks, Mathias Hänel, Rüdiger Liersch, Jan Dürig, Christiane Pott, Eva Hoster, Michael Unterhalt, Wolfgang Hiddemann

Tam Metin Erişim

<i>Erratum</i> to: “Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma All... Yazar: Christian Schmidt, Gabriel Scheubeck, Vindi Jurinovic, Martin Sökler, Roswitha Forstpointner, Christian Buske, Andreas Viardot, Ulrich Keller, Ullrich Graeven, Reinhard Marks, Mathias Hänel, Rüdiger Liersch, Jan Dürig, Christiane Pott, Eva Hoster, Michael Unterhalt, Wolfgang Hiddemann

Tam Metin Erişim

PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotype Yazar: Sebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig, Claudia D. Baldus, Hubert Serve, Carsten Müller-Tidow, Kerstin Schäfer-Eckart, Martin Kaufmann, Stefan W. Krause, Mathias Hänel, Andreas Neubauer, Gerhard Ehninger, Uwe Platzbecker, Martin Bornhäuser, Johannes Schetelig, Jan M. Middeke, Christian Thiede

Tam Metin Erişim

Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients Yazar: Niels Weinhold, Hans J. Salwender, David A. Cairns, Marc S. Raab, George Waldron, Igor W. Blau, Uta Bertsch, Thomas Hielscher, Gareth J. Morgan, Anna Jauch, Faith E. Davies, Mathias Hänel, Gordon Cook, Christoph Scheid, Richard Houlston, Hartmut Goldschmidt, Graham Jackson, Martin F. Kaiser

Tam Metin Erişim

How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective Yazar: Ann-Cathrine Siefen, Ann-Cathrine Siefen, Melina Sophie Kurte, Melina Sophie Kurte, Florian Jakobs, Marcel Teichert, Bastian von Tresckow, Hans Christian Reinhardt, Udo Holtick, Johannes Atta, Christian Jehn, Elisa Sala, Anke Warnecke, Mathias Hänel, Christof Scheid, Florian Kron, Florian Kron, Florian Kron

Tam Metin Erişim

RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma Yazar: Martina Emde-Rajaratnam, Susanne Beck, Susanne Beck, Vladimir Benes, Hans Salwender, Uta Bertsch, Christoph Scheid, Mathias Hänel, Katja Weisel, Thomas Hielscher, Marc S. Raab, Hartmut Goldschmidt, Hartmut Goldschmidt, Anna Jauch, Ken Maes, Elke De Bruyne, Eline Menu, Kim De Veirman, Jérôme Moreaux, Karin Vanderkerken, Anja Seckinger, Dirk Hose

Tam Metin Erişim

Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studie... Yazar: Carsten Hirt, Eva Hoster, Michael Unterhalt, Mathias Hänel, Gabriele Prange-Krex, Roswitha Forstpointner, Axel Florschütz, Ullrich Graeven, Norbert Frickhofen, Gerald Wulf, Eva Lengfelder, Christian Lerchenmüller, Rudolf Schlag, Judith Dierlamm, Ludwig Fischer von Weikersthal, Asima Ahmed, Hanns-Detlev Harich, Andreas Rosenwald, Wolfram Klapper, Martin Dreyling, Wolfgang Hiddemann, Michael Herold

Tam Metin Erişim

COVID‐19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post‐Pandemic Concerns About the Impact of... Yazar: Christian Ammitzbøll, Marianne Kragh Thomsen, Lars Erik Bartels, Cecilie Bo Hansen, Marie‐Louise From Hermansen, Mathias Hänel, Rasmus Klose‐Jensen, Mads Lamm Larsen, Morgan Oliver Lauritsen, Clara Elbæk Mistegaard, Susan Mikkelsen, Janne Bille Mønster Olesen, Esben Uggerby Næser, Morten Aagaard Nielsen, Christian Erikstrup, Peter Garred, Ellen‐Margrethe Hauge, Anne Troldborg

Tam Metin Erişim

S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE... Yazar: Andreas Hochhaus, Andreas Burchert, Susanne Saußele, Gabriela M Baerlocher, Jiri Mayer, Tim H Brümmendorf, Paul La Rosee, Dominik Heim, Stefan W Krause, Philipp Le Coutre, Christian Fabisch, Jenny Rinke, Thoralf Lange, Alice Fabarius, Marcel Lorch, Mathias Hänel, Frank Stegelmann, Georg-Nikolaus Franke, Markus Radsak, Volker Kunzmann, Danny Himsel, Denise Kohn, Thomas Lang, Rüdiger Hehlmann, Thomas Ernst, Markus Pfirrmann

Tam Metin Erişim

Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD Yazar: Sonia Jaramillo, Lucian Le Cornet, Markus Kratzmann, Johannes Krisam, Martin Görner, Mathias Hänel, Christoph Röllig, Maxi Wass, Sebastian Scholl, Mark Ringhoffer, Alexander Reichart, Björn Steffen, Sabine Kayser, Jan-Henrik Mikesch, Kerstin Schaefer-Eckart, Jörg Schubert, Thomas Geer, Sonja Martin, Meinhard Kieser, Tim Sauer, Katharina Kriegsmann, Michael Hundemer, Hubert Serve, Martin Bornhäuser, Carsten Müller-Tidow, Richard F. Schlenk

Tam Metin Erişim

Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trial Yazar: Lisa B. Leypoldt, Linlin Guo, Britta Besemer, Mathias Hänel, Marc-S. Raab, Christoph Mann, Christian S. Michel, Hans Christian Reinhardt, Igor Wolfgang Blau, Martin Görner, Yon-Dschun Ko, Maike de Wit, Hans Salwender, Christof Scheid, Ullrich Graeven, Rudolf Peceny, Peter Staib, Annette Dieing, Hartmut Goldschmidt, Carsten Bokemeyer, Tanja Zeller, Dirk Westermann, Katja C. Weisel, Raphael Twerenbold, Antonia Beitzen-Heineke

Tam Metin Erişim

Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib Yazar: Benjamin Hanfstein, Michael Lauseker, Rüdiger Hehlmann, Susanne Saussele, Philipp Erben, Christian Dietz, Alice Fabarius, Ulrike Proetel, Susanne Schnittger, Claudia Haferlach, Stefan W. Krause, Jörg Schubert, Hermann Einsele, Mathias Hänel, Jolanta Dengler, Christiane Falge, Lothar Kanz, Andreas Neubauer, Michael Kneba, Frank Stegelmann, Michael Pfreundschuh, Cornelius F. Waller, Karsten Spiekermann, Gabriela M. Baerlocher, Markus Pfirrmann, Joerg Hasford, Wolf-Karsten Hofmann, Andreas Hochhaus, Martin C. Müller

Tam Metin Erişim

T002: Treatment related morbidity in patients with classical Hodgkin Lymphoma: results of the ongoing, randomized phase III HD21 Trial by The German Hodgkin Study Group Yazar: Peter Borchmann, Alden Moccia, Richard Greil, Mark Herzberg, Alexander Fosså, Andreas Hüttmann, Felix Keil, Judith Dierlamm, Valdete Schaub, Mathias Hänel, Urban Novak, Julia Meissner, Johannes Hellmuth, Stephan Mathas, Josée. M. Zijlstra, Andreas Viardot, Bernd Hertenstein, Sonja Martin, Pratush Giri, Stefanie Kreissl, Michael Fuchs, Gundolf Schneider, Andreas Rosenwald, Wolfram Klapper, Hans Theodor Eich, Christian Baues, Michael Hallek, Carsten Kobe, Volker Diehl, Andreas Engert

Tam Metin Erişim

Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and <i>KIT</i> and/or <i>FLT3</i>- ITD mutations: results of the SAL MIDOKIT trial Yazar: Leo Ruhnke, Christoph Röllig, Sylvia Herold, Tim Sauer, Christian H. Brandts, Björn Steffen, Kerstin Schäfer-Eckart, Stefan W. Krause, Mathias Hänel, Albrecht Reichle, Sebastian Scholl, Andreas Neubauer, Jan-Henrik Mikesch, Johannes Schetelig, Friedrich Stölzel, Michael Kramer, Annett Haake, Julia Frimmel, Alwin Krämer, Richard Schlenk, Uwe Platzbecker, Hubert Serve, Claudia D. Baldus, Carsten Müller-Tidow, Daniela Aust, Martin Bornhäuser, Gerhard Ehninger, Christian Thiede

Tam Metin Erişim

Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study Yazar: Dietger Niederwieser, Dirk Hasenclever, Wolfgang Berdel, Bart J. Biemond, Haifa Al-Ali, Yves Chalandon, Michel van Gelder, Christian Junghanß, Gösta Gahrton, Mathias Hänel, Rüdiger Hehlmann, Thomas Heinicke, Andreas Hochhaus, Simona Iacobelli, Rien van Marwijk Kooy, Nicolaus Kröger, Jeroen Janssen, Madlen Jentzsch, Frank Breywisch, Mohamad Mohty, Stavroula Masouridi-Levrat, Gert Ossenkoppele, Jacob Passweg, Wolfram Pönisch, Johannes Schetelig, Christoph Schliemann, Sebastian Schwind, Matthias Stelljes, Leo F. Verdonck, Vladan Vucinic, Bob Löwenberg, Jan Cornelissen

Tam Metin Erişim

Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning Yazar: Jan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, Michael Kramer, Sebastian Stasik, Julia-Annabell Georgi, Peter Heisig, Karsten Spiekermann, Utz Krug, Jan Braess, Dennis Görlich, Cristina M. Sauerland, Bernhard Woermann, Tobias Herold, Wolfgang E. Berdel, Wolfgang Hiddemann, Frank Kroschinsky, Johannes Schetelig, Uwe Platzbecker, Carsten Müller-Tidow, Tim Sauer, Hubert Serve, Claudia Baldus, Kerstin Schäfer-Eckart, Martin Kaufmann, Stefan Krause, Mathias Hänel, Christoph Schliemann, Maher Hanoun, Christian Thiede, Martin Bornhäuser, Karsten Wendt, Jan Moritz Middeke

Tam Metin Erişim

Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysis Yazar: Nico Gagelmann, Hermann Einsele, Sarah Flossdorf, Samih Smaili, Klaus Metzeler, Christoph Scheid, Lars Bullinger, Sandra Sauer, Marc Raab, Justus Duyster, Hans Christian Reinhardt, Raphael Teipel, Winfried Alsdorf, Claudia Lengerke, Wolfgang Herr, Natalie Schub, Francis Ayuketang Ayuk, Florian Bassermann, Christian Schultze-Florey, Roland Schroers, Mathias Hänel, Nicola Giesen, Ahmet Elmaagacli, Andreas Burchert, Thomas Weber, Dimitrios Mougiakakos, Stefan Knop, Fabian Müller, Nicolaus Kröger, Maximilian Merz, the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy, DRST

Tam Metin Erişim